FSGS Recurrence Collaboration: Report of a symposium
Since it was first described more than 50 years ago, recurrence of FSGS in kidney allografts has frustrated the transplant community. This rare condition is associated with considerable morbidity, and it is the most common cause of graft loss in patients with CKD stage 5 due to FSGS. However, the pr...
Main Authors: | Debbie S. Gipson, Chia-shi Wang, Eloise Salmon, Rasheed Gbadegesin, Abhijit Naik, Simone Sanna-Cherchi, Alessia Fornoni, Matthias Kretzler, Sandra Merscher, Paul Hoover, Kelley Kidwell, Moin Saleem, Leonardo Riella, Lawrence Holzman, Annette Jackson, Opeyemi Olabisi, Paolo Cravedi, Benjamin Solomon Freedman, Jonathan Himmelfarb, Marina Vivarelli, Jennifer Harder, Jon Klein, George Burke, Michelle Rheault, Cathie Spino, Hailey E. Desmond, Howard Trachtman |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-11-01
|
Series: | Glomerular Diseases |
Online Access: | https://beta.karger.com/Article/FullText/535138 |
Similar Items
-
CUBN gene mutations may cause focal segmental glomerulosclerosis (FSGS) in children
by: Jing Yang, et al.
Published: (2022-01-01) -
A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design
by: Michelle N. Rheault, et al.
Published: (2023-05-01) -
Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases
by: Mengyuan Ge, et al.
Published: (2021-08-01) -
The epidemiology of primary FSGS including cluster analysis over a 20-year period
by: Thomas McDonnell, et al.
Published: (2023-12-01) -
Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS
by: Thomas Osterholt, et al.
Published: (2023-04-01)